Details for Patent: 9,254,286
✉ Email this page to a colleague
Which drugs does patent 9,254,286 protect, and when does it expire?
Patent 9,254,286 protects ZERVIATE and is included in one NDA.
Protection for ZERVIATE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-three patent family members in seven countries.
Summary for Patent: 9,254,286
Title: | Ophthalmic formulations of cetirizine and methods of use |
Abstract: | The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye. |
Inventor(s): | Abelson; Mark B. (Andover, MA), Chapin; Matthew J. (Amesbury, MA), Gomes; Paul (Haverhill, MA), Minno; George (Suwanee, GA), Nice; Jackie (Medford, MA) |
Assignee: | Aciex Therapeutics, Inc. (Boston, MA) |
Application Number: | 12/724,128 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Delivery; Device; |
Drugs Protected by US Patent 9,254,286
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,254,286
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2755679 | ⤷ Try a Trial | |||
European Patent Office | 2408453 | ⤷ Try a Trial | |||
European Patent Office | 2547340 | ⤷ Try a Trial | |||
European Patent Office | 3943069 | ⤷ Try a Trial | |||
Spain | 2910374 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |